Trial Profile
Open Label Phase II Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 16 Apr 2015 New trial record